KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ionis Pharmaceuticals (IONS) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Ionis Pharmaceuticals (IONS) over the last 16 years, with Q3 2025 value amounting to $213000.0.

  • Ionis Pharmaceuticals' Tax Provisions rose 10588.24% to $213000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.4 million, marking a year-over-year decrease of 17772.29%. This contributed to the annual value of -$6.2 million for FY2024, which is 11909.28% down from last year.
  • Per Ionis Pharmaceuticals' latest filing, its Tax Provisions stood at $213000.0 for Q3 2025, which was up 10588.24% from -$20000.0 recorded in Q2 2025.
  • Ionis Pharmaceuticals' Tax Provisions' 5-year high stood at $11.4 million during Q1 2023, with a 5-year trough of -$3.6 million in Q3 2024.
  • Moreover, its 5-year median value for Tax Provisions was $300000.0 (2022), whereas its average is $2.0 million.
  • As far as peak fluctuations go, Ionis Pharmaceuticals' Tax Provisions skyrocketed by 222091.69% in 2022, and later tumbled by 15484.7% in 2024.
  • Ionis Pharmaceuticals' Tax Provisions (Quarter) stood at $349000.0 in 2021, then surged by 2220.92% to $8.1 million in 2022, then dropped by 19.8% to $6.5 million in 2023, then tumbled by 141.12% to -$2.7 million in 2024, then soared by 107.97% to $213000.0 in 2025.
  • Its last three reported values are $213000.0 in Q3 2025, -$20000.0 for Q2 2025, and $116000.0 during Q1 2025.